Beth Israel Deaconess Medical Center is notifying more than 2,000 patients of a potential breach of protected health information (PHI) that resulted from a vendor's failure to restore security controls following routine maintenance.

Cardinal Health officially opened the $11 million Center for the Advancement of Molecular Imaginga new, collaborative laboratory that will seek to develop nuclear imaging agents that treat complex diseases like cancer, heart disease and neurological disordersin Phoenix on July 18.

American Wells Online Care Suite has received the federal governments meaningful use stamp of approval by earning EHR modular certification.

The FDA has notified the public and the medical imaging community about the potential for inadvertent, increased radiation exposure in patients who underwent or will be undergoing cardiac PET scans with rubidium-82 (Rb-82) chloride injection from CardioGen-82 (Bracco Diagnostics).

St. Jude Medical has received European CE Mark approval for its Ilumien system, a diagnostic technology that combines optical coherence tomography (OCT) and fractional flow reserve (FFR) technologies on one platform.

A $2 million upgrade to an x-ray analytical device was completed through a collaboration with Eli Lilly's research arm and the U.S. Department of Energy's Argonne National Laboratory.

Males are significantly more likely to die from most cancers than females, a risk that mirrors a higher incidence of cancer among men, according to a study published in the August issue of Cancer Epidemiology, Biomarkers & Prevention.

A proposed FDA rule requiring a unique identification system for medical devices is scheduled for release this September, according to a Semiannual Regulatory Agenda of the Department of Health and Human Services.